Sanofi MS drug nears green light after pass-the-parcel marathon

[riky]

Sanofi MS drug nears green light after pass-the-parcel marathon

By Ben Hirschler LONDON (Reuters) - One of the world's longest running drug development sagas may draw to a close this month as French firm Sanofi hopes for a European green light for its new multiple sclerosis medicine Lemtrada. The drug's quarter-century journey from a laboratory in Cambridge, England, to a possible $1 billion-a-year seller has involved a string of pass-the-parcel deals that serve as an object lesson in complex "drug dealing" between rival companies. ...

Source: You are not allowed to view links. Register or Login